MedPath

Exergaming in People With Major Neurocognitive Disorder

Not Applicable
Conditions
Randomised Controlled Trial
Long-term Care Facility
Physical Activity
Cognitive Impairment
Major Neurocognitive Disorder
Interventions
Device: Exergame device
Registration Number
NCT04436302
Lead Sponsor
Davy Vancampfort
Brief Summary

This randomized controlled trial explores the efficacy of an 8-week standing exergaming program in people with major neurocognitive disorder (MNCD) residing in long-term care facilities.

Detailed Description

This randomized controlled trial explores the efficacy of an 8-week standing exergaming program in people with major neurocognitive disorder (MNCD) residing in long-term care facilities. Fifty inpatients with mild to moderate MNCD will be randomly assigned to three times weekly for eight weeks 15 min of exergaming versus watching preferred music videos. The Montréal Cognitive Assessment (MoCA), Short Physical Performance Battery (SPPB), Neuropsychiatric Inventory (NPI), Cornell Scale for Depression in Dementia (CSDD), Dementia Quality of Life (DQoL), Katz activities of daily living (ADL) and Instrumental ADL (IADL) are measured at baseline and post intervention.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
InterventionExergame deviceDividat senso exergame device
ControlExergame deviceListening to music
Primary Outcome Measures
NameTimeMethod
NPI2 years

Neuropsychiatric Inventory

(I)ADL2 years

Activities of daily living

SPPB2 years

Short Physical Performance Battery

CSDD2 years

Cornell Scale for Depression in Dementia

DQOL2 years

Dementia Quality of Life

MoCA2 years

Montréal Cognitive Assessment

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Long-term care facility 'de Wingerd'

🇧🇪

Leuven, Vlaams Brabant, Belgium

© Copyright 2025. All Rights Reserved by MedPath